Skip to main content
ADCES24 Main banner
Back
Video

On-Demand

Technology Integration

F25 - Understand the Limitations of CGM Metrics: Nothing is Perfect

Friday, August 9, 2024
3:50 PM – 4:35 PM CT
CE/CME Hours: .75
CE/CME Hours: .75
Pharmacology Hours: 0.0
Activity Type: Knowledge
UAN: JA4008258-0000-24-096-L01-P
CHES/MCHES: .75
HbA1c has been the gold standard for monitoring glycemic management of diabetes, but it has some limitations. CGM metrics help optimize diabetes care, but there are also limitations that health professionals should consider. This session highlights these limitations through case scenarios and discussion. Presenters will review key findings from recent publications on CGM metrics, their correlation with HbA1c, and their association with diabetes complications.

    Primary Presenter(s)

  • Viral N. Shah, MD (he/him/his)

    Professor of Medicine, Division of Endocrinology & Metabolism
    Indiana University School of Medicine
    Indianapolis, Indiana

    Disclosure(s): ASCENSIA Diabetes Care: Consultant / Advisory Board (Ongoing); Dexcom: Consultant / Advisory Board (Ongoing); Embecta: Consultant / Advisory Board (Ongoing); Insulet: Consultant / Advisory Board (Ongoing), Research (Ongoing); NovoNordisk: Consultant / Advisory Board (Ongoing), Research (Ongoing); Sanofi: Consultant / Advisory Board (Ongoing); Tandem Diabetes Care: Consultant / Advisory Board (Ongoing), Research (Ongoing)

    Slides Slide Player

    • Co-Presenter(s)

  • John Daniel Ruck, DNP, FNP, BC-ADM, ADCES (he/him/his)

    Doctor of Nursing Practice
    Joslin Diabetes Center / Harvard Medical Faculty Physicians
    Boston, Massachusetts

    Disclosure(s): Ascenscia Diabetes: Consultant / Advisory Board (Terminated, January 1, 2022); Lifescan: Consultant / Advisory Board (Terminated, August 1, 2022); Sanofi: Speakers' Bureau (Ongoing); Sequel Medical Technology: Consultant / Advisory Board (Ongoing)

    • Moderator(s)

  • Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES (she/her/hers)

    Assistant Professor of Medicine/Program Director Diabetes Technology
    Case Western Reserve University/University Hospitals
    Shaker Heights, Ohio

    Disclosure(s): Abbott: Speakers' Bureau (Ongoing); ASCENSIA Diabetes Care: Speakers' Bureau (Ongoing); Embecta: Consultant / Advisory Board (Ongoing); MannKind: Speakers' Bureau (Ongoing); Medtronic: Speakers' Bureau (Ongoing); Sanofi: Speakers' Bureau (Ongoing)